Table 4 Secondary outcomes
Secondary outcomes | Baseline versus W12 change | W12 versus W24 change | Other time points |
|---|---|---|---|
Muscle mass | X | X | |
Muscle strength: knee and handgrip | X | X | |
Body composition | X | X | |
Balance | X | X | W1, W2, W4, W6, W8 and W10 in participants with exercise intervention to follow progression |
Frailty | X | X | |
Sarcopenia | X | X | |
Activities of daily living | X | X | |
Physical behaviour | X | X | |
Quality of life | X | X | |
Number of falls and fear of falling | X | X | |
Malnutrition | X | X | W6 |
Cognitive functioning | X | X | |
Dietary intake | X | X | W1, W3, W11 |
Use of health care | X | X | W1, W4, W8, W16, W20, W22, |
Benefits and adverse events | W1, W4, W8, W16, W20, W22, W24 | ||
Blood measures | X | X | Vit D: screening |
Subjective compliance with the interventions and vitamin D intake | X | W1, W2, W4, W6, W8 and W10 | |
Objective compliance with the interventions | X | ||
Muscle parameters | X |